Non-steroidal anti-inflammatory drug-induced apoptosis in gastric cancer cells is blocked by protein kinase C activation through inhibition of c-myc

[1]  J. Lord,et al.  Isoenzymes of protein kinase C: differential involvement in apoptosis and pathogenesis. , 1997, Molecular pathology : MP.

[2]  W. Rom,et al.  Novel Form of p21WAF1/CIP1/SDI1 Protein in Phorbol Ester-induced G2/M Arrest* , 1996, The Journal of Biological Chemistry.

[3]  A. Sytkowski,et al.  Protein kinase C-epsilon is necessary for erythropoietin's up-regulation of c-myc and for factor-dependent DNA synthesis. Evidence for discrete signals for growth and differentiation. , 1996, The Journal of biological chemistry.

[4]  B. Rigas,et al.  Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway. , 1996, Biochemical pharmacology.

[5]  D. Hicks,et al.  Differential Growth Inhibition by the Aspirin Metabolite Salicylate in Human Colorectal Tumor Cell Lines: Enhanced Apoptosis in Carcinoma and in Vitro-transformed Adenoma Relative to Adenoma Cell Lines , 1996 .

[6]  I. Grosman,et al.  Genomania of p53 protein in gastric cancer. , 1996, Journal of clinical gastroenterology.

[7]  B. Dynlacht,et al.  The anti-proliferative effect of sulindac and sulindac sulfide on HT-29 colon cancer cells: alterations in tumor suppressor and cell cycle-regulatory proteins. , 1996, Oncogene.

[8]  A. Culhane,et al.  Apoptosis: molecular regulation of cell death. , 1996, European journal of biochemistry.

[9]  B. Rigas,et al.  Nonsteroidal antiinflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: effects on cell cycle and apoptosis. , 1996, Experimental cell research.

[10]  G. Prendergast,et al.  c-Myc induces apoptosis in epithelial cells by both p53-dependent and p53-independent mechanisms. , 1995, Oncogene.

[11]  V. Sánchez-Margalet,et al.  Protein kinase C involvement in apoptosis. , 1995, General pharmacology.

[12]  D. Reed,et al.  Nonsteroidal antiinflammatory drugs cause apoptosis and induce cyclooxygenases in chicken embryo fibroblasts. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[13]  B. Hoffman,et al.  Molecular controls of growth arrest and apoptosis: p53-dependent and independent pathways. , 1995, Oncogene.

[14]  J. Cidlowski,et al.  Cell cycle and apoptosis: Common pathways to life and death , 1995, Journal of cellular biochemistry.

[15]  N. Hay,et al.  Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1. , 1994, Genes & development.

[16]  P. Hall,et al.  Regulation of cell number in the mammalian gastrointestinal tract: the importance of apoptosis. , 1994, Journal of cell science.

[17]  M. Takao,et al.  The development of the endothelin-1-induced gastric ulcer: time sequence analysis of morphologic changes. , 1994, International journal of experimental pathology.

[18]  E. Rimm,et al.  Aspirin Use and the Risk for Colorectal Cancer and Adenoma in Male Health Professionals , 1994, Annals of Internal Medicine.

[19]  D. Givol,et al.  Induction of WAF1/CIP1 by a p53-independent pathway. , 1994, Cancer research.

[20]  Stephen S. Gisselbrecht,et al.  Activation of cyclin A-dependent protein kinases during apoptosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[21]  S. Grant,et al.  Induction of apoptotic DNA fragmentation and cell death in HL-60 human promyelocytic leukemia cells by pharmacological inhibitors of protein kinase C. , 1994, Cancer research.

[22]  Yi-Song Wang,et al.  WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. , 1994, Cancer research.

[23]  David Beach,et al.  p21 is a universal inhibitor of cyclin kinases , 1993, Nature.

[24]  S. Hirohashi,et al.  p53 Mutation in gastric cancer: A genetic model for carcinogenesis is common to gastric and colorectal cancer , 1993, International journal of cancer.

[25]  S. Piantadosi,et al.  Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. , 1993, The New England journal of medicine.

[26]  M. Thun,et al.  Aspirin use and risk of fatal cancer. , 1993, Cancer research.

[27]  J. F. Fraumeni,et al.  Incidence of cancer among patients with rheumatoid arthritis. , 1993, Journal of the National Cancer Institute.

[28]  M. Clemens,et al.  The role of protein kinase C isoenzymes in the regulation of cell proliferation and differentiation. , 1992, Journal of cell science.

[29]  P. Lin,et al.  Potentiation of the activity of 1-beta-D-arabinofuranosylcytosine by the protein kinase C activator bryostatin 1 in HL-60 cells: association with enhanced fragmentation of mature DNA. , 1992, Cancer research.

[30]  L. Marnett Aspirin and the potential role of prostaglandins in colon cancer. , 1992, Cancer research.

[31]  Gerard I. Evan,et al.  Induction of apoptosis in fibroblasts by c-myc protein , 1992, Cell.

[32]  T Matozaki,et al.  Missense mutations and a deletion of the p53 gene in human gastric cancer. , 1992, Biochemical and biophysical research communications.

[33]  J. Cleveland,et al.  Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. , 1991, Oncogene.

[34]  J. Minna,et al.  Chemosensitivity testing of human lung cancer cell lines using the MTT assay. , 1988, British Journal of Cancer.

[35]  P. K. Smith,et al.  Measurement of protein using bicinchoninic acid. , 1985, Analytical biochemistry.

[36]  R. Rhoads Ovalbumin messenger ribonucleic acid. Purification and fractionation on the basis of polyadenylate content by thermal elution from oligodeoxythymidylate-cellulose. , 1975, The Journal of biological chemistry.

[37]  Y. Chung,et al.  Overexpression of c-myc messenger RNA in primary and metastatic lesions of carcinoma of the stomach. , 1996, Journal of the American College of Surgeons.

[38]  D. Hicks,et al.  Differential growth inhibition by the aspirin metabolite salicylate in human colorectal tumor cell lines: enhanced apoptosis in carcinoma and in vitro-transformed adenoma relative to adenoma relative to adenoma cell lines. , 1996, Cancer research.

[39]  J. Lotem,et al.  Regulation by bcl-2, c-myc, and p53 of susceptibility to induction of apoptosis by heat shock and cancer chemotherapy compounds in differentiation-competent and -defective myeloid leukemic cells. , 1993, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[40]  Z. Darżynkiewicz,et al.  Features of apoptotic cells measured by flow cytometry. , 1992, Cytometry.

[41]  T. Hakulinen,et al.  Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis. , 1978, Journal of chronic diseases.